About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

29

Jan

2016

Change Healthcare (Emdeon): Notification of System Maintenance

Effective: Friday -February 5, 2016

On Friday, January 22nd, Change Healthcare made a difficult decision to ‘pause’ the migration of the SelectRx claims adjudication application due to circumstances beyond our control. Over the last few days, we have taken steps to address and mitigate what was beyond our control and reschedule the migration of SelectRx for the weekend of February 5, 2016.   That being said, the system will be unavailable Friday, February 5th  beginning at 11:50 pm EASTERN and is anticipated to be returned online late morning on Saturday, February 6th.   During this time, pharmacy will receive the following rejection response from Change Healthcare’s switch.             ERX03: Connection to Payer Down     For your convenience I’ve attached a list of BINS that will be impacted during our down time.   We appreciate your patience!

29

Jan

2016

Change Healthcare (Emdeon): Notification of System Maintenance

Efective: February 1, 2016

Effective 2/1/2016 Effective February 1, 2016 Cigna-HealthSpring is changing the disposition of the Duplicate Therapy Alert (DUPTHER) for the therapeutic class Oral Antipsychotics. Duplicate Therapy identifies when a member takes two or more prescriptions that provide the same therapeutic effect. The new alert status for Duplicate Therapy will be set to reject (DUR Reject 88) at POS (point-of -service) and require pharmacies to review and override the rejected claim using the appropriate DUR/PPS Clarification Codes.

29

Jan

2016

CVS/caremark: RXPCN Required WellCare Health Plans

As previously communicated, effective January 1, 2016, CVS/caremark began to administer the prescription benefits for WellCare Health Plans. Beginning January 28, 2016, claims submitted with an incorrect RXPCN will reject with the following or similar message: Reject 85 : <Claim Not Processed> <Submit RxPCN MCAIDADV> To minimize disruption, please update member profiles with this RXPCN. RXBIN: 004336 RXPCN: MCAIDADV RXGRP: Varies by plan/state. Use the information printed on the member’s ID card or see table below. Note : Pharmacy network participation varies by plan and region. Your pharmacy may not participate in all plans for WellCare.

28

Jan

2016

OptumRx: IMPORTANT INFORMATION REGARDING Recall of Sodium Chloride, Metronidazole and Clinimix E Injectable Products by Baxter

Effective: January 21, 2016

On January 21, 2016, Baxter announced a recall of some lots of 0.9% sodium chloride injection, metronidazole 500 mg/100 mL injection, and Clinimix E 5/15 injection because of the presence of cardboard fragment particulate matter and leaks from some units of sodium chloride injection, cloth fiber particulate matter in a unit of metronidazole injection, and dried skin particulate matter in a unit of Clinimix E injection. Per Baxter, the leak may result in contamination of the drug product, leading to potential bloodstream infections and other adverse events. Injection of particulate matter may result in blocked blood vessels, stroke, heart attack, and other serious adverse events. Catamaran, an OptumRx Company, notified members who may be affected by this recall. These members were provided information to help them identify if their medication is being recalled. In the future, these members may inquire about the sodium chloride injection, metronidazole injection, and/or Clinimix E injection prescription(s) you dispensed. If you have any questions, please call Baxter at 800-437-5176 (8:00 am – 5:00 pm CT, Monday through Friday) for more information about this recall.

First 751752753754 Last